1-Naphthoxyacetic acid is a synthetic auxin, a plant hormone that plays a crucial role in regulating plant growth and development. It is known for its strong auxin activity and has been extensively studied for its potential applications in agriculture, horticulture, and plant biotechnology. The compound is typically synthesized by reacting 1-naphthol with chloroacetic acid in the presence of a base. 1-Naphthoxyacetic acid is a potent stimulator of root formation and cell elongation. It is used to promote root development in plant cuttings, induce adventitious rooting, and control plant growth. It also exhibits herbicidal activity, making it a potential candidate for weed control. Research on 1-naphthoxyacetic acid focuses on understanding its mechanism of action, optimizing its application for specific purposes, and exploring its potential for enhancing plant productivity and resilience. The compound is also being investigated for its potential in plant tissue culture, as well as its role in plant-microbe interactions. Overall, 1-naphthoxyacetic acid is a valuable research tool and a potential candidate for various applications in agriculture and plant science.'
ID Source | ID |
---|---|
PubMed CID | 76313 |
CHEMBL ID | 1234781 |
CHEBI ID | 44588 |
SCHEMBL ID | 120838 |
MeSH ID | M0070316 |
Synonym |
---|
EN300-17267 |
CHEMBL1234781 |
acetic acid, (1-naphthalenyloxy)- |
einecs 221-023-4 |
9qi2464poa , |
unii-9qi2464poa |
nsc 9847 |
smr000136050 |
MLS000531067 |
(1-naphthyloxy)acetic acid |
AE-842/05917051 |
EU-0033255 |
2976-75-2 |
nsc-9847 |
nsc9847 |
OPREA1_372975 |
naphthyloxyacetic acid |
SR-01000596923-2 |
CHEBI:44588 , |
1-naphthyloxyacetic acid |
(naphthalen-1-yloxy)acetic acid |
1-naphthoxyacetic acid |
(1-naphthalenyloxy)acetic acid |
1-naphthoxyacetic acid, 98% |
STK062342 |
ghrysofwkrrlmi-uhfffaoysa- |
2-naphthalen-1-yloxyacetic acid |
inchi=1/c12h10o3/c13-12(14)8-15-11-7-3-5-9-4-1-2-6-10(9)11/h1-7h,8h2,(h,13,14) |
AKOS000101578 |
DB08286 |
F0701-0149 |
N0046 |
NCGC00245781-01 |
2-(1-naphthyloxy)acetic acid |
2-(naphthalen-1-yloxy)acetic acid |
CCG-46746 |
HMS2445M14 |
FT-0608116 |
BBL023242 |
2-(1-naphthoxy)acetic acid |
naphthoxy-acetic acid |
SCHEMBL120838 |
2M-936 |
acetic acid, 2-(1-naphthalenyloxy)- |
naphthalene 1-carboxymethyl ether |
1-naphthalenyloxyacetic acid |
J-200034 |
.alpha.-naphthoxyacetic acid |
(1-naphthoxy)acetic acid |
(1-naphthyloxy)acetic acid # |
HMS3604M14 |
acetic acid,2-(1-naphthalenyloxy)- |
mfcd00003927 |
DTXSID30183911 |
SR-01000596923-1 |
sr-01000596923 |
1-naphthoxyacetic acid, analytical standard |
2-(naphthalen-1-yloxy)aceticacid |
Q27097509 |
1-naphthoxy acetic acid |
a-naphthoxy acetic acid |
CS-0072894 |
T72248 |
A876391 |
SY048215 |
Z56900768 |
Class | Description |
---|---|
naphthyloxyacetic acid | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 31.6228 | 0.0040 | 23.8416 | 100.0000 | AID485290 |
Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 6.3096 | 0.1778 | 14.3909 | 39.8107 | AID2147 |
Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 50.1187 | 5.6234 | 17.2929 | 31.6228 | AID485281 |
ClpP | Bacillus subtilis | Potency | 15.8489 | 1.9953 | 22.6730 | 39.8107 | AID651965 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 39.8107 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
PINK1 | Homo sapiens (human) | Potency | 12.5893 | 2.8184 | 18.8959 | 44.6684 | AID624263 |
Parkin | Homo sapiens (human) | Potency | 12.5893 | 0.8199 | 14.8306 | 44.6684 | AID624263 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 4.4668 | 0.0355 | 20.9770 | 89.1251 | AID504332 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 22.3872 | 0.0018 | 15.6638 | 39.8107 | AID894 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (9.52) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 10 (47.62) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.67) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |